• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to footer
Mass Tort News

Mass Tort News

News Articles for Mass Tort Attorneys

  • Facebook
  • LinkedIn
  • Twitter
  • YouTube
  • Home
  • News
  • LegalCast
  • Live Trials
  • Contact Us
Home / Opioid Crisis / Why Were Insys Therapeutics, Inc. and CEO John Kapoor Indicted and Not The Sacklers and Purdue Pharma? A Retrospective Look Back to the 2018 Insys Criminal Indictments

Why Were Insys Therapeutics, Inc. and CEO John Kapoor Indicted and Not The Sacklers and Purdue Pharma? A Retrospective Look Back to the 2018 Insys Criminal Indictments

Categories: Consumer Protection, Current Litigation, Opioid Crisis Tags: consumer protection, current litigation, opioid crisis, purdue pharma, sackler familyAugust 26, 2021 by Mark York Leave a Comment

Why Were Insys Therapeutics, Inc. and CEO John Kapoor Indicted and Not The Sacklers and Purdue Pharma? A Retrospective Look Back to the 2018 Insys Criminal Indictments 

The Opioid Crisis Behind The Scenes

by Mark A. York (June 8, 2018 original date)

(revised with additional comments August 25, 2021)

Subsys – an Insys Therapeutics, Inc. Pharmaceutical Opioid Product

Why have the Sacklers and Purdue Pharma slipped through the criminal indictment noose since the 2018 opioid litigation explosion, unlike John Kapoor and c-suite at Insys Therapeutics, Inc?  It seems that the Sacklers and the influence not only in the US but internationally is paying big dividends as of August 2021.

The entire exec team at Insys, as well as the sale department were all indicted, albeit there were fraudulent insurance transactions and certain other pay-to-play assertions made in the Insys indictments and subsequent trials.  The fact remains, the primary issue was off-label marketing and causing deaths to consumers who were misled by the corporate marketing and sales practice of the Insys Therapeitics board room, which eventually fell on the shoulders of founder and CEO John Kapoor.  Kapoor now sits in a federal prison, post January 2020 66 month prison sentence.  Why was Insys & Crew the only major opioid big pharma criminal indictment to come from the opioid litigation fallout in 2017-2018?  

To compound things even further in this retrospective of Insys-Kapoor in 2018 and Purdue-Sacklers in 2021, the harsh scrutiny is, Insys Therapeutics new CEO Saeed Motahari, moved over from Purdue Pharma and the Sacklers, the one and only Oxycontin maker. Purdue is charged with false marketing, off-label use and ignoring the Oxycontin highly addictive dangers for years, while bringing in literally billions of dollars in profits, but Purdue’s transgressions are in Part 2 of our ongoing reports on big pharma and opioid abuses.

Just as WalMart slipped through the criminal indictment noose, that was weeks from being filed during the Trump Administration, the Sackler sense of entitlement shows how the white collar c-suite power reflects that money and influence will protect corporate America, if it will result in political blowback in Washington, DC. Clearly showing that the federal government is at times, a prejudicial and selective enforcement entity, that won’t cross over the white collar lines if the intended criminal targets are the select cadre of corporate influencers in the United States and Around the world.

WalMart Indictment

In the spring of 2018, the Eastern District of Texas informed Walmart that it was preparing criminal charges, what happened to the indictment still remains a mystery. Although, the failure of the criminal charges to be filed is purported to have emboldened WalMart so much, that they ended up filing litigation in the  USDC of Texas, attempting to escape the Opioid MDL 2804 docket altogether. It often pays to have friends in high places. How that plays out on the opioid settlement stage, remains to be seen, as the pharmacies will be the last man standing when it comes to writing checks and are clearly seen as a deep pocket.

See the WalMart outside counsel letter to the US Department of Justice meetings with WalMart’s outside counsel Jones Day:  https://www.documentcloud.org/documents/6818268-Letter-From-K-Hewitt-to-B-Benczkowski-Aug-10.html

For the entire WalMart criminal indictment failure by the US DoJ see:

https://www.propublica.org/article/walmart-was-almost-charged-criminally-over-opioids-trump-appointees-killed-the-indictment.

Originally Article in 2018, a retrospect:

“How Insys Therapeutics, Inc. Sold Stock and Killed Americans With The help of Doctors” H

(Mass Tort News) Here’s a perfect example of how corporate greed and licensed medical providers helped create the now rampant US opioid crisis– how payments to doctors and prescribers across the country caused addictive painkillers, like “Subsys” a fentanyl based opioid, to suddenly rip through our country like a flash fire.

Insys Therapeutics,a publicly traded pharmaceutical company based in Arizona, is just one small example of what Big Pharma has been doing for the last 10 years in every city and state in the United States, often increasing corporate earnings right alongside the catastrophic opioid related death rates. For Insys Theraputics executives, the sales team and its nationwide cadre of fraudulent doctors, the results have been felony indictments and long federal prison sentences, with many more to come.

INSYS EXECUTIVES INDICTED

December 2016 saw Insys Therapeutics CEO Michael Babich and five other senior executives indicted on criminal charges for paying kickbacks and bribes to medical professionals and committing fraud against insurance companies across the country for offering a highly addictive Fentanyl prescription product “Subsys” to the masses. The Insys boardroom was indicted in the US District Court of Massachusetts, where the entire team has engaged a stable of top national law firms to defend the indictments. The “Subsys” sales teams were charged in federal indictments across the country, including Arkansas, Connecticut, Alaska and New York and the indictments will only increase as those cases proceed and “cooperating witnesses” decide that prison isn’t an option.

To compound further harsh scrutiny for Insys, it’s new CEO Saeed Motahari, moved over from Purdue Pharmaceuticals, the Oxycontin maker, who’s also a major target of criminal and civil investigations across the country by local state and federal agencies. Purdue is charged with false marketing, off-label use and ignoring the Oxycontin highly addictive dangers for years, while bringing in literally billions of dollars in profits, but Purdue’s transgressions are in Part 2 of our ongoing reports on big pharma and opioid abuses.

DOCTORS FACING NUMEROUS CHARGES

Doctors and their pain clinics, medical centers and other healthcare facilities have been indicted for fraudulent prescription writing, submitting false claims to insurance companies and numerous other federal charges and all face a minimum of 20 to 50 years in federal prison. Two of the busiest “Subsys” prescription writers in the country were Alabama doctors, John Couch and Xiulu Ruan, who earned over $40 million from Insys, and were charged with running a pill mill between 2013 and 2015, have been convicted and sentenced to 20 years each in federal prison. The top “Subsys: prescriber of all, Dr. Gavin Awerbach, of Saginaw, MI pled guilty to defrauding Medicare and Blue Cross out of $3.1 million in improper Subsys prescriptions, his criminal sentence is pending. To show the far reach of Insys and it’s corporate plans to saturate the US market with opioids, in Anchorage, Alaska Dr. Mahmood Ahmad, was charged with heading a massive Subsys prescribing operation, which he denies, but immediately surrendered his Alaska medical license which the caused the revocation of his medical license in Arkansas.

INSURANCE COMPANIES FILED SUIT

Adding weight to this tragedy is Anthem Insurance — you may recognize them as Blue Cross, one of the largest insurers in the country, now setting their sights on Insys Theraputics and it’s executives.

Anthem is suing Insys Therapeutics, the maker of the powerful opioid Subsys, for allegedly lying, cheating and defrauding its way into the medicine cabinets of Anthem clients across the country. The drug according to Anthem’s complaint, was off market prescribed to thousands of patients for years. Review shows that 54% of patients who are taking Subsys don’t really have cancer — one of the requirements for prescribing the drug, Subsys was FDA approved for “treatment of pain related to cancer” and any other use is unauthorized or off-label use.

Anthem says that’s because Insys devised an elaborate scheme to get around Anthem’s system — by falsifying records and posing as medical professionals, often with the complete knowledge and cooperation of medical doctors across the country who then received thousands of dollars in kickbacks. These doctors chose to exchange high fees from Insys in exchange for writing off-label prescriptions to patients seeking pain relief for non-life threatening conditions.

Anthem claims it ultimately paid $19 million more for Subsys than it should have. “But the harm inflicted by Insys’s conduct is not merely financial in nature,” the complaint states “Insys put Anthem’s members’ health at risk.”

THE OFF LABEL CAMPAIGN

The only people who are supposed to be taking Subsys are adult cancer patients, according to the FDA “Subsys” approval files, anything other than that is an “off label” indication. Now you can take a drug to treat something off label if you want to, but you have to get your doctor to get pass a prior authorization.

Anthem alleges that Insys has an entire unit to get around this requirement — it’s titled the “reimbursement unit.” Investigative journalists exposed this fraud initially as far back as 2015 on behalf of the Southern Investigative Reporting Foundation, see Insys Therapeutics “Subsys” Off Label Rx Fraud.

The Reimbursement Unit claim was basically the company’s fraudulent  prescription approval factory, which helped participating doctors process claims (the doctors had so many they couldn’t handle them all). The unit falsified records to show patients had cancer and called insurers, pretending to be patients or other medical professionals, to facilitate approval of payment for off-label treatment.

This is the Unit’s script for obtaining off-label approval (taken from the Anthem suit):

The script read: “The physician is aware that the medication is intended for the management of breakthrough pain in cancer patients. The physician is treating the patient for their pain (or breakthrough pain, whichever is applicable).” The script deliberately omitted the word “cancer as applied to the patient treatment under discussion.”

DO STOCKS RISE AND FALL ON INDICTMENTS

In late 2016 the entire top level of Insys executives, including former CEO Michael Babich, and five others were indicted and charged with multiple counts of fraud and conspiracy. Since then a number of sales reps and medical practitioners have pled guilty to charges that they gave or accepted kickbacks in furtherance of the fraudulent prescription scheme. The manager of reimbursement services, Elizabeth Gurrieri, pleaded guilty to wire fraud in June. There have been numerous deaths and related overdoses attributed to the over prescribing of Subsys across the country, which to date, show most parties involved being able to avoid the scrutiny of criminal charges related to off-label marketing and prescribing. Insys has tried to re-shuffle the executive board by bringing in new members, but business as usual in the Big Pharma boardroom goes on, as they simply brought in other more experienced “opioid industry” insiders to help further the continued use of “Subsys” and purportedly the major Insys New Pharma” entry, a line of complex medical marijuana products, that may enable them to shake off the current Insys label as the United States leading “opioid abuse by boardroom design” corporation.

As part of the boardroom strategy to get doctors to prescribe Subsys, Insys spent millions paying them off through a fraudulent “speakers program” meant to educate medical professionals about the drug. The speaking engagements were a veiled attempt to cover-up the direct payment to doctors for writing prescriptions, the more prescriptions you wrote, the higher your “speaking fees” increased. There are e-mails, texts and other Insys communications from all levels of company personnel stating “if they not writing prescription, they’re off the speaking program”, this policy resulted in one Alabama sales rep being paid over $700 thousand in Subsys based Rx commissions for one year, while her base salary was $40 thousand.

“While the exact amount of those kickbacks has yet to be determined, criminal indictments of the recipients indicate that Insys paid “speaker fees” of millions, of dollars, which may result in additional criminal charges against the doctors as well as the doctors facility staff who often worked hand in hand with Insys staff.

SALES REP NATALIE REED PERHAC

In the plea, Perhacs admitted that she was hired to be the personal sales representative for one of Insys’s most important prescribers, Dr. Xiulu Ruan. Ruan is one of two Alabama doctors who picked up over $115,000 in speaker fees from 2012 to 2015, and earned in excess of $40 million in related medical earnings during the same period. Earlier this year they were sentenced to 20 years in jail each for running a “pill mill” and helping Insys sales rep Natalie Reed Perhacs sell Subsys, for which she was paid in excess of $700 thousand in commissions, see Perhac Guilty Plea in Alabama Federal Court.

Perhac Plea Excerpts:

Admision No. 78: . Perhacs admitted that her primary responsibility at Insys was to increase the volume of Subsys® prescribed by Dr. Ruan, and his partner Dr. John Patrick Couch. This… was accomplished by (1) handling prior authorizations for their patients who had been prescribed Subsys®; (2) identifying patients who had been at the same strength of Subsys® for several months and recommending that Dr. Ruan or Dr. Couch increase the patients’ prescription strength; and (3) setting up and attending paid speaker programs.

Admission No. 79:. Ms. Perhac admitted that because of her involvement in the prior authorization process, she knew that the vast majority of Dr. Ruan and Dr. Couch’s patients did not have breakthrough cancer pain.

As you can see by the Perhac admissions, numbers 78 and 79, which reflect the vast number of charges lodged against her, the federal government is cracking down on everyone involved with the “Subsys” fraud. According to confidential sources, the recent June 2017 FDA “Opioid Crisis” Conference and related strategic review of the opioid crisis, will result in many more indictments and charges against drug makers and the medical providers who’ve helped facilitate the opioid epidemic that is currently in place across the United States.

Disclaimer: Certain excerpts and comments within this article are re-use of previously published publicly available media materials, no rights to or ownership is asserted herein.

Feel free to contact us if you have a story or interest in publishing an article through one of our media formats below.

Mass Tort News

Washington, DC

[email protected]

[email protected]

MassTortNews.org

MassTortNews.live

To watch the New York Opioid Trial live on a daily basis visit masstortnews.live to access and watch the New York Opioid trial live in the State Of New York, et al vs.  Opioid Manufacturers and Distributors.

Click To View

Mark York
Mark York
masstortnews.org/
Share on Facebook Share
Share on TwitterTweet
Share on LinkedIn Share
Send email Mail

Categories: Consumer Protection, Current Litigation, Opioid Crisis Tags: consumer protection, current litigation, opioid crisis, purdue pharma, sackler family

Reader Interactions

Leave a Reply Cancel reply

You must be logged in to post a comment.

Primary Sidebar

Search

E-mail Newsletter

Sign up to receive weekly updates on the latest in Mass Tort News.

Recent Episodes

John K. Rabiej served as the Deputy Director of the Bolch Judicial Institute for one year, and as the Director of the Duke Law Center for Judicial Studies for seven years. The Duke Law Center brings together judges, lawyers, researchers, government officials and other parties to advance the study and understanding of the judicial process and generate ideas for how it might be improved. During his time as the Director of the Duke Law Center, Mr. Rabiej studied the impact of technology on the judiciary, including analyzing his concerns that the courts are not keeping pace with the rapid advancement of technology in the culture at large. Prior to joining the Duke Law Center, Mr. Rabiej served as the Executive Director and Director of Judicial Outreach for The Sedona Conference; the Chief of the Rules Committee Support Office; and the American Law Institute. He presently sits on the Chief Justice’s Rules Advisory Commission, North Carolina (term ending December 31, 2023). In this episode of LegalCast, Mr. Rabiej discusses a legal bipartisan review of mass torts, class action, and the ever-expanding e-discovery quagmire that seems to be firmly embedded in complex litigation coming to a peak in 2022.  Will the plaintiffs and defense leadership be able to collaborate to reign in the ever-expanding high cost of litigation? Mr. Rabiej has made a career of working to bring opposing groups together to discuss common interests as a means to increase efficiencies in litigations. And, with millions of dollars at stake, why not at least start the discussions.

Remember to subscribe and follow us on social media…

LinkedIn: https://www.linkedin.com/company/mass-tort-news
Twitter: https://www.twitter.com/masstortnewsorg
Facebook: https://www.facebook.com/masstortnews.org
Is Judicial Review On The Horizon?
YouTube Video VVVuSC1KSll3UzVNWHQwMEgyUndoR3Z3LmlkM1ZiUVJMYkdZ
Stephen P New. of Beckley West Virginia is one of the country’s leading opioid litigators, by bringing the fight directly to Opioid Big Pharma's doorstep. Steve and the Opioid Justice Team have been defending and advocating for the rights of the neonatal abstinence syndrome afflicted infants, aka the "NAS Babies." Who are the truly innocent victims of the now decades-old opiate crisis in America.

Remember to subscribe and follow us on social media…

LinkedIn: https://www.linkedin.com/company/mass-tort-news
Twitter: https://www.twitter.com/masstortnewsorg
Facebook: https://www.facebook.com/masstortnews.org
Leading the Fight for Opioid Addicted Infants
YouTube Video VVVuSC1KSll3UzVNWHQwMEgyUndoR3Z3LnhNbHdDSGU3ZzZZ
George Haj is a Pulitzer-Prize winning editor who founded Haj Media in 2017. Haj Media is a strategic communications firm focusing on crisis communications, media relations, and litigation support for law firms and corporate clients. Prior to launching his own consulting firm, George spent three decades working in some of the nation’s largest news organizations. He has deep roots in the media industry and connections with reporters and editors in a range of publications across the country. George worked as executive business editor at the Miami Herald and then was a top editor at the Houston Chronicle. He also served as editorial director of ALM Media, where he directed a global newsroom of more than 100 journalists and oversaw iconic brands including The American Lawyer and National Law Journal. He can be reached at george@hajmedia.com. Find him on Twitter: https://twitter.com/georgehaj, LinkedIn: https://www.linkedin.com/in/george-haj-25ba481, and at http://www.hajmedia.com/. 

Remember to subscribe and follow us on social media…

LinkedIn: https://www.linkedin.com/company/mass-tort-news
Twitter: https://www.twitter.com/masstortnewsorg
Facebook: https://www.facebook.com/masstortnews.org
Crisis Management & Media Training for Lawyers
YouTube Video VVVuSC1KSll3UzVNWHQwMEgyUndoR3Z3LmhvVDk2Q2MxUnpR
With four decades of experience in legal advertising with a passion for legal marketing, intake, and conversion, Harlan Schillinger has more than earned his title as the Grandfather of Legal Advertising. 

Harlan was the first in the industry to produce and market TV advertising for the legal community. In 1975, along with his partners, Harlan founded the first syndication TV production firm for high-end retailers and Lawyers, creating television commercials that aired throughout North America.

Since the late 1970s, Harlan has worked aggressively, productively, and professionally within the legal advertising space. He has said that: “Creating opportunities and increasing market share for advertising law firms is [his] #1 priority. The value of the case is everything in such a crowded market.” Harlan privately consults with lawyers who not only share his values, but who also share his vision of increasing business, being accountable, and obtaining high-value cases. His approach to intake and conversion rests on complete accountability within that area and he is known to practice what he preaches. Harlan has trademarked within the legal advertising world the two phrases that have become his backbone of philosophy: What You Don't Know, You Don't Know® and Ambassador of First Impressions™.

Since that time, Harlan has worked with more than 130 law firms in almost 100 markets throughout North America. Before joining Network Affiliates in 1985, Harlan was a founding partner and VP of Madison, Muyskens & Jones, a Connecticut-based advertising agency. In April 2016 Harlan retired from Colorado-based Network Affiliates, the nation's first and largest full-service legal advertising agency, where he was the leader of their attorney marketing efforts for over 34 years.

A few years ago, Harlan and two of his partners – Dino Colombo Esq. and Eric Coffman – developed Lead Docket, software for intake and conversion within law firms. Harlan says that Lead Docket helps law firms increase control and management of intake and conversion, allowing the firms to thrive.

Harlan is involved with a number of professional organizations, being a member of the National Trial Lawyers Executive Summit Committee as well as a Senior Editor and Writer for the National Trial Lawyers Magazine. He also has a passion for riding and building custom motorcycles, and is a proud member of the most prestigious motorcycle group in the world: Hamsters USA ® Motorcycle Group.

Learn more about Harlan at http://www.harlanschillinger.com/. 
And to check out the book he recommends – How to Win Friends & Influence People by Dale Carnegie and originally published in 1936 click here: https://www.amazon.com/How-Win-Friends-Influence-People/dp/0671027034. 

Remember to subscribe and follow us on social media…

LinkedIn: https://www.linkedin.com/company/mass-tort-news
Twitter: https://www.twitter.com/masstortnewsorg
Facebook: https://www.facebook.com/masstortnews.org
Prep Like a Pro: Legal Networking Tips & Tricks
YouTube Video VVVuSC1KSll3UzVNWHQwMEgyUndoR3Z3LjJJRW9MWUh1UkZ3
Christos Lagos has been the co-managing partner of Lagos & Priovolos PLLC since 2014 when he and John Priovolos formed the firm. Christos, who has over 23 years of legal experience, heads the firm's civil litigation division. His primary focus is on claims that involve substantial losses arising out of construction negligence, unsafe premises, automobile and trucking accidents, medical malpractice, wrongful death, negligence, defective products, insurance claims, and other civil disputes. 
 
Christos is a seasoned and accomplished trial lawyer with an exceptional track record of success handling high-profile litigation. His experience as lead counsel in numerous jury trials has proven invaluable in the guidance and expertise he offers his clients. He has obtained several multi-million dollar settlements, judgments, and jury verdicts and is a standing member of both the Million Dollar Advocates Forum and the Multi-Million Dollar Advocates Forum. In total, Christos has helped recover over $150 Million for those whose lives have been harmed by the wrongdoing of others. 
 
Over the last 20 years, Christos has successfully litigated against insurance companies, construction and engineering firms, major consumer product and automobile manufacturers, property owners, health care providers, trucking and transportation companies, and other entities and corporations. Christos holds a Certificate in Mass-Tort Multidistrict Litigation (MDL) from the Bolch Judicial Institute at Duke Law School. Throughout his career, Christos has handled several notable landmark cases. Notably, Christos filed the first wrongful death lawsuit for the tragic bridge collapse that occurred at Florida International University. Twenty personal injury and wrongful death cases were consolidated against twenty-eight defendants involving over 100 lawyers.  Christos served as Liaison Counsel and was a lead attorney in this consolidated action. On behalf of all plaintiffs' counsel, Christos conducted numerous presentations and led global settlement negotiations resulting in the creation of a trust for the benefit of the bridge collapse victims in the amount of $102.75 Million from twenty-five defendants. 
 
Judge Jennifer D. Bailey, Administrative Judge of the Eleventh Judicial Circuit in Miami-Dade County, who presided over the FIU bridge collapse litigation, had this to say about him: 
 
"Everyone should be extraordinarily grateful for Mr. Lagos's service as the lead court liaison. A significant portion of why this case has moved as efficiently as it has is because he stepped up to do this."

 - Honorable Judge Jennifer D. Bailey
Administrative Judge, Circuit Civil Division
Eleventh Judicial Circuit of Florida in and for Miami-Dade County

To view news clips and statements from Judge Bailey and other counsel involved in the FIU bridge collapse litigation, click here: https://vimeo.com/694264408/f5251ce891 . 
 
Read more about Christos here: http://www.lpesq.com/ . And connect with him on LinkedIn here: https://www.linkedin.com/in/christoslagos/ . 

Remember to subscribe and follow us on social media…

LinkedIn: https://www.linkedin.com/company/mass-tort-news
Twitter: https://www.twitter.com/masstortnewsorg
Facebook: https://www.facebook.com/masstortnews.org
Mass Tort Tragedy: the FIU Bridge Collapse with Christos Lagos
YouTube Video VVVuSC1KSll3UzVNWHQwMEgyUndoR3Z3LkFJWVoycXk2SE5V
Vicki J. Maniatis is a partner at Milberg Coleman Bryson Phillips Grossman who has worked on mass tort cases involving pharmaceuticals and medical devices for seventeen years. She is a frequent invited lecturer and moderator on a wide variety of pharmaceutical and mass tort cases including, Opioids, Trans Vaginal Mesh, Fosamax, Ortho Evra, Risperdal, Propecia, Avandia, Onglyza, as well as several medical devices. Vicki has been appointed by State and Federal Judges to serve as lead counsel and on Plaintiffs’ steering committees. She has significant experience performing all levels of bellwether trial case-specific work up including, plaintiff, spouse and family member depositions, implanting, explanting, treating physicians, sales representative, and expert depositions, for over 30 cases in several mass torts including TVM, Mirena and Propecia cases.

Vicki serves as a founding member of Mass Tort Med School, an annual medical seminar for Plaintiffs’ attorneys that offers numerous physician speakers and cutting-edge medical issues. In May 2022, along with the Trial Lawyers of Puerto Rico, Mass Tort Med School is hosting Mass Torts Puerto Rico, a first-of-its-kind program where attorneys will have the opportunity to learn from and connect with world-class trial lawyers and experts – the Mass Tort Med School program will be bigger and better than ever.

Remember to subscribe and follow us on social media…

LinkedIn: https://www.linkedin.com/company/mass-tort-news
Twitter: https://www.twitter.com/masstortnewsorg
Facebook: https://www.facebook.com/masstortnews.org
The Expert Whisperer with Vicki Maniatis
YouTube Video VVVuSC1KSll3UzVNWHQwMEgyUndoR3Z3Lk9UQWlzZUhSVllz
Pedram Esfandiary is an attorney in the Los Angeles office of Baum Hedlund Aristei & Goldman, where he concentrates his practice on toxic tort injuries, pharmaceutical drug liability, class actions, consumer fraud litigation and police misconduct lawsuits.

He currently leads the firm’s legal team that is filing lawsuits against manufacturers of baby food for knowingly selling baby food with with “dangerously high levels” of toxic heavy metals. This new mass tort litigation involves allegations against the major brand manufacturers (Nurture Happy Family Organics, Beech-But, Hain, Plum Organics, Walmart-Parent’s Choice, Sprout Foods and Gerber) that their baby food contains dangerous levels of arsenic, cadmium, lead and mercury, which are all considered toxic heavy metals and are known to damage neurological development and brain development in infants and are associated with autism and ADHD in children.

Pedram was an integral part of the trial team that won the historic $2 billion verdict against Monsanto (now Bayer) in May 2019 on behalf of a couple who together sprayed Roundup weed killer on their properties for 30 years. The jury awarded Alva and Alberta Pilliod $55 million in compensatory damages. Pedram was also served in a similar capacity on the very first Roundup cancer case to go to trial against Monsanto, resulting in a $289 million verdict on behalf of groundskeeper Dewayne “Lee” Johnson. And he participated in the second Roundup trial against Monsanto on behalf of Edwin Hardeman. The jury in that trial awarded Mr. Hardeman $80 million for his damages.

A winner on Law360’s Rising Stars Top 40 Under 40 list for 2019, Pedram has been recognized as an attorney whose legal accomplishments transcends his age. He has also been selected to Southern California Super Lawyers® – Rising Stars and the National Trial Lawyers Top 40 Under 40.
Read Pedram’s full bio on the Baum Hedlund website here.

Remember to subscribe and follow us on social media…

LinkedIn: https://www.linkedin.com/company/mass-tort-news
Twitter: https://www.twitter.com/masstortnewsorg
Facebook: https://www.facebook.com/masstortnews.org
Toxic Heavy Metals in Baby Food with Pedram Esfandiary
YouTube Video VVVuSC1KSll3UzVNWHQwMEgyUndoR3Z3LnRUQU5GZTh0OGpr
LegalCast spent a few minutes with 1st-year law student, Bailey Webster, at the 4th Annual Class Action Law Forum, at her school, Univ of San Diego. Bailey is very dynamic, engaging as well as being forward-thinking 8n how she sees herself as both a student, but also an up-and-coming legal professional. 

Watch and listen as one of America's emerging lawyers states clearly, how and why she chose law as a career and how she's shaping her own future.  

Bailey is definitely a young lawyer to keep an eye on in the future, "that's for all you recruiters at the tier one firms." 

Kudos to the USD School of Law class of 2024 for attracting students like Bailey.

Remember to subscribe and follow us on social media…

LinkedIn: https://www.linkedin.com/company/mass-tort-news
Twitter: https://www.twitter.com/masstortnewsorg
Facebook: https://www.facebook.com/masstortnews.org

http://www.westernalliancebancorporation.com/
Minute with Mark - Decisions, Decisions: Class action, commercial lit, intellectual property?
YouTube Video VVVuSC1KSll3UzVNWHQwMEgyUndoR3Z3LjJuYXlJYVdXZEZj
Hello America's law firms, meet Arif Salam, the type of up-and-coming lawyer in a 1st-year law student, who you want to get on your firm's radar. 

Arif has chosen class action law as his practice area of choice, already making inroads and connections by interacting with senior Class Action lawyers at the 4th annual class action law forum hosted by the University of San Diego school of law, where Arif is a first-year student.

Motivated and confident enough to interact with lead class action counsel from across the country and very capable of holding his own in a discussion that not many 1st years are given the opportunity to engage in. A legal mover in the making 'Arif Salam." 

Remember to subscribe and follow us on social media…

LinkedIn: https://www.linkedin.com/company/mass-tort-news
Twitter: https://www.twitter.com/masstortnewsorg
Facebook: https://www.facebook.com/masstortnews.org

http://www.westernalliancebancorporation.com/
Minute with Mark - 1st year at Univ of SD School of Law? Is class action law for me?
YouTube Video VVVuSC1KSll3UzVNWHQwMEgyUndoR3Z3LjN2NVh3TS1Mci1v
Jason Velez is a partner at the Cochran Firm in its Salt Lake City and St. George offices in Utah. He is also the Founder and CEO of 1Law https://www.1law.com, a company that leverages artificial intelligence to make lawyers more efficient and lower costs for consumers. By doing so, 1Law helps drive new business to attorneys, which in turn improves the user experience for consumers.  
 
1Law utilizes artificial intelligence to augment, rather than replace lawyers’ ability to provide top-notch legal services to their clients. The 1Law platform allows lawyers and clients to communicate, share information, and access information on a real-time basis, from anywhere. Built on cutting-edge technology, 1Law helps improve access to justice by making quality legal representation available to all through the profitability of personal injury law. 
 
Connect with Jason on LinkedIn here.

Remember to subscribe and follow us on social media…

LinkedIn: https://www.linkedin.com/company/mass-tort-news
Twitter: https://www.twitter.com/masstortnewsorg
Facebook: https://www.facebook.com/masstortnews.org
THE VALUE OF LEGAL TECHNOLOGY with Jason Velez
YouTube Video VVVuSC1KSll3UzVNWHQwMEgyUndoR3Z3LlZIMjRHMEFIcUNj
Load More... Subscribe

Popular Tags

current litigationopioid crisisconsumer protectioncovid-19emerging tortszantacpurdue pharmaeventsackler familyjuul

Footer

Search

Main Navigation

  • Home
  • News
  • LegalCast
  • Live Trials
  • Contact Us

Categories

Events

Trial Lawyers Summit 2022

February 16, 2022 By Mass Tort News

2021 Trial Lawyers Summit Recap

May 11, 2021 By Mark York

2021 TRIAL LAWYERS SUMMIT

May 4, 2021 By Mass Tort News

More Posts from this Category

MASS TORT NEWS

Latest Mass Tort Litigation News

  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

Copyright © 2022 · Mass Tort News · All Rights Reserved.